Source: https://pubs.rsc.org/-/content/articlehtml/2016/ce/c6ce01594h
Timestamp: 2019-04-22 22:53:54+00:00

Document:
The syntheses and crystal structures of [CuI2(phbpz)]·MeOH (lp-CFA-9, lp = large-pore) and [CuI2(phbpz)] (np-CFA-9, np = narrow-pore; H2-phbpz = 3,3′,5,5′-tetraphenyl-1H,1′H-4,4′-bipyrazole) are described. The copper(I)-containing metal–organic framework (termed oordination ramework ugsburg University-9, lp-CFA-9) crystallizes in the trigonal crystal system, within the chiral space group P3221 (no. 154) and with the following unit cell parameters: a =18.2348(6), c = 16.3950(4) Å, and V = 4721.1(2) Å3. Lp-CFA-9 features a 3-D microporous framework structure of Cu4pz4 (pz = pyrazolate) SBUs with the D2d (= 2m) symmetry connected by single bonds creating one-dimensional channels expanding in the c-direction of the crystal lattice. The framework flexibility of CFA-9 has been demonstrated by single-crystal and powder X-ray analyses as well as by sorption measurements. CFA-9 exhibits weak binding of carbon monoxide on Cu(I) centers. The reactivity of CFA-9 towards oxidizing agents, such as H2O2, t-BuOOH and Br2 was also investigated. Additionally, CFA-9 shows luminescence upon exposure to UV radiation.
On the other hand, copper-based MOFs have attracted particular interest, which relates to the role of copper centers in the active sites of metalloenzymes, such as oxidases or oxygenases.16 Biologically inspired MOF catalysts hold great promise for a wide range of synthetic applications in the oxidation of organic intermediates containing non-activated C–H bonds. Few reports on applications of Cu-MOFs as oxidation catalysts have appeared in the literature. In particular, Cu-catalyzed hydroxylation of phenol,17 oxidation of trimethylsilyl enolates to α-hydroxyketones,18 allylic oxidation of cyclohexene,19 cross-dehydrogenative coupling reactions of ethers with 2-carbonyl-substituted phenols,20 oxidation of benzene derivatives and benzylic compounds21 and arylation of heteroarenes22 have been described.
Here, we report on the synthesis and characterization of a new Cu(I)-MOF, termed CFA-9 ( oordination ramework ugsburg University-9), featuring a flexible 3-D microporous framework structure of Cu4pz4 (pz = pyrazolate) SBUs connected to each other by single bonds (Scheme 1). The Cu4pz4 structure motif is rather uncommon and only a few examples of crystalline compounds containing a Cu4pz4 unit can be found in the literature, e.g. a discrete metal complex [Cu4(HL2)2] (H3L2 = 1,3,5-tris((3,5-diphenyl-1H-pyrazol-4-yl)methyl)benzene)27 and a metal–organic framework Cu2L (L = 3,3′,5,5′-tetraethyl-4,4′-bipyrazolate) including two types of SBUs, namely, triangular Cu3pz3 units and saddle-type Cu4pz4 units.28 The flexibility of the CFA-9 framework is demonstrated by single-crystal and powder X-ray analyses as well as by gas sorption measurements. CFA-9 is characterized by elemental and thermogravimetric analyses, variable temperature powder X-ray diffraction, and IR and luminescence spectroscopy. Additionally, the reactivity of CFA-9 towards oxidizing agents, such as H2O2, t-BuOOH and Br2 is reported.
Scheme 1 Syntheses of [CuI2(phbpz)]·2DEF·MeOH (CFA-2) and [CuI2(phbpz)]·MeOH (CFA-9) from the H2-phbpz ligand and copper(II) acetate (DEF = N,N-diethylformamide).
The 3,3′,5,5′-tetraphenyl-1H,1′H-4,4′-bipyrazole ligand (H2-phbpz) was synthesized according to a modified published procedure.26,29Lp-CFA-9 was synthesized by a solvothermal reaction starting from a Cu(II)-salt Cu(OAc)2·H2O and a 3,3′,5,5′-tetraphenyl-1H,1′H-4,4′-bipyrazole ligand in a MeOH/2,6-lutidine system, giving colourless hexagonal prismatic crystals (Fig. 1).
Fig. 1 SEM image (left) and optical micrograph (right) of CFA-9 crystals.
Interestingly, slight changes of reaction conditions (a mixed-solvent system N,N-diethylformamide/EtOH/Et3N was used instead of the aforementioned solvent) results in the formation of the Cu(I)-MOF CFA-2 (Scheme 1). CFA-2, featuring a 3-D three-connected two-fold interpenetrated porous structure constructed of triangular Cu(I) subunits and 3,3′,5,5′-tetraphenyl-1H,1′H-4,4′-bipyrazolate (phbpz) ligands, exhibits a pronounced breathing effect upon exposure to different guest molecules.
Additionally, applying microwave irradiation in the synthesis of CFA-9, instead of conventional heating, allowed us to reduce the reaction time drastically, from 3 d to 25 min.
[CuI2(phbpz)]·MeOH (lp-CFA-9). Lp-CFA-9 crystallizes in the trigonal crystal system within the chiral space group P3221 (no. 154). The asymmetric unit consists of three copper, four nitrogen, thirteen carbon and twenty hydrogen atoms. An Ortep-style plot of the asymmetric unit of lp-CFA-9 is shown in the ESI,† Fig. S1. Lp-CFA-9 features a 3-D non-interpenetrated microporous structure constructed from Cu4pz4 secondary building units with the D2d (= 2m) symmetry, each containing a tetranuclear coordination unit of four Cu(I) ions and four pyrazolate ligands, as shown in Fig. 2a and b. The Cu(I) ions within each SBU are two-fold coordinated in a nearly linear arrangement by pyrazolate N-donor atoms from the ligand molecules; the N–Cu–N dihedral angles, therefore, are close to 180° (171.6(3), 172.9(2), 177.7(3)°). The four central Cu(I) ions are in the same plane, whereas two phbpz2− ligands are positioned above and below this plane, thus building a saddle-shaped structure (see Fig. 2a). The intramolecular Cu⋯Cu distances range from 3.0252(7) to 3.1829(1) Å. The Cu–N distances range from 1.840(3) to 1.847(3) Å. These values are in good agreement with those found in the structurally related Cu-MOF, Cu2L (L = 3,3′,5,5′-tetraethyl-4,4′-bipyrazolate),28 and copper(I)-containing compounds.27 The phenyl groups of each bipyrazolate linker are twisted with respect to each other and are disordered.
Fig. 2 (a) Coordination unit of the CFA-9 framework featuring tetranuclear Cu(I) moieties. (b) Representation of the SBU of CFA-9. Phenyl groups were omitted for clarity. (c) Schematic packing diagram representing SBUs of lp-CFA-9, viewed in the c-direction. The dotted lines represent the unit cell of lp-CFA-9 after transformation to the orthorhombic crystal system. (d) Packing diagram of lp-CFA-9 with channels, viewed in the c-direction. Disordered phenyl rings and solvent molecules, as well as hydrogen atoms were omitted for clarity. (e) Schematic packing diagram representing SBUs of the desolvated phase of np-CFA-9, viewed in the c-direction. (f) Packing diagram of np-CFA-9, viewed in the c-direction.
The SBUs of lp-CFA-9 are connected by single bonds and create one-dimensional channels expanding in the c-direction of the crystal lattice (see Fig. 2c and d). Taking the van der Waals radii of hydrogen atoms (1.2 Å) into account, the narrowest channel diameter calculated between the hydrogen atoms of the phenyl groups is 5.96 Å. Estimation using the SQUEEZE30 program reveals that the initial solvent accessible void volume is 664.7 Å3, or 0.118 cm3 g−1, which is 14.1% of the unit cell volume (4721.1(2) Å3) for a probe radius of 2.07 Å, corresponding to the approximate van der Waals radius of carbon dioxide.31 In the crystal structure of lp-CFA-9, the channels are occupied by disordered MeOH molecules. The positions of the solvent molecules were impossible to resolve and refine from the electron density distribution. According to the crystallographic data, there is an electron count of 114 per unit cell, which corresponds to 6.5 MeOH molecules in the unit cell of lp-CFA-9. Removal of the solvent by drying and/or heating the sample leads to structural changes. Due to the fact that the lp-CFA-9 and np-CFA-9 structures are described in different crystal systems with different space groups which do not have a direct group–subgroup relation between them, the hexagonal unit cell of lp-CFA-9 was transformed to the orthorhombic one (see Fig. 2c–f). Direct comparison of the unit cells indicates that the structural transition from the solvated sample (lp-CFA-9) to a desolvated one (np-CFA-9) is connected with the dynamic shortening of the a- (from 18.23 to 18.09 Å) and b-lattice parameters (from 31.58 Å to 28.18 Å) and slight elongation of the c-parameter (from 16.40 to 16.72 Å). This process is accompanied by the unit cell volume change from 9442 Å3 (lp-CFA-9) to 8524 Å3 (np-CFA-9). The framework flexibility results from the properties of the tetraphenylbipyrazolate ligand where two pyrazolate rings can rotate around the central C–C single bond. In lp-CFA-9, the angle between the planes created by pyrazolate rings is 60.7°, while in np-CFA-9 the angle value ranges from 65.0 to 65.5° (see Fig. 3). The intramolecular Cu⋯Cu distances in np-CFA-9 range from 3.049(3) to 3.129(1) Å. The Cu–N distances range from 1.774(15) to 1.916(13) Å (see the ESI,† Table S1). Taking the van der Waals radii of hydrogen atoms (1.2 Å) into account, the narrowest channel diameter calculated between the hydrogen atoms of the Ph-groups in np-CFA-9 is 4.07 Å, while the smallest aperture of the channel is 2.27 Å. Estimation using the SQUEEZE30 program reveals that the initial solvent accessible void volume is 566.5 Å3, or 0.046 cm3 g−1, which is 6.6% of the unit cell volume (8524.4(11) Å3) for a probe radius of 2.07 Å,31 corresponding to the approximate van der Waals radius of carbon dioxide.
Fig. 3 Structural overlay of the SBUs of lp-CFA-9 and np-CFA-9 (lp-CFA-9 – SBU in black, np-CFA-9 – two different SBUs in red and green).
Topology analysis using the TOPOS program32 (see the ESI†) reveals that the lp-CFA-9 and np-CFA-9 coordination networks can be described as chiral qtz (quartz) nets by regarding the Cu4pz4 SBUs as four-connected nodes and the phbpz2− ligands as spacers (see the ESI† and Fig. 4).
Fig. 4 (a) Simplified diagram of the SBUs of CFA-9. Topological representation of lp-CFA-9 (b) and np-CFA-9 (c).
The crystal structure transformation from the solvated state to the desolvated one and back upon immersing the dried sample in polar solvents (MeOH, DEF, NMP) is dynamic and reversible, as confirmed by XRPD studies.
Microcrystalline powder samples of CFA-9 were exposed to air for a long period of time; the colour change of the sample from white to light green after several months reflects very slow oxidation of the Cu(I) ions. The phase purity of CFA-9 was confirmed by XRPD measurement under ambient conditions. The experimental XRPD pattern of the wet sample (a) is consistent with the simulated one (b), as gleaned from the single crystal X-ray diffraction data, as shown in Fig. 5. Differences in peak intensities are due to occluded solvent molecules. Similarly, the experimental XRPD pattern of the dried sample (c) is consistent with the simulated one (d), as gleaned from the single crystal X-ray diffraction data.
Fig. 5 Calculated and measured X-ray powder patterns for CFA-9. (a) Calculated pattern of lp-CFA-9; (b) measured pattern of lp-CFA-9; (c) calculated pattern of np-CFA-9; (d) measured pattern of np-CFA-9; and (e) dried sample re-solvated by DMF.
In addition, the thermal stability of CFA-9 was determined by thermogravimetric (TG) and VTXRPD measurements. Prior to the measurements, the sample was heated at 100 °C under vacuum for 2 h in order to remove occluded solvent molecules (MeOH). As shown in Fig. 6, the thermogravimetric profile of CFA-9 under nitrogen exhibits a weight loss of 31% between 570 and 650 °C, while under oxygen a weight loss of 73% occurs between 350 and 400 °C. In both cases, the steps are connected with the degradation of the compound. According to the VTXRPD data presented in Fig. 7, the sample is stable up to ca. 450 °C (measurement in a capillary). Above 500 °C, Cu (PDF no. 3-1015) was detected. Removal of the solvent by drying and/or heating the sample leads to XRPD pattern changes, which is connected with the structural changes of the compound. Interestingly, the XRPD pattern of the CFA-9 sample heated at 100 °C for 0.5 h under vacuum can be recovered after the desolvated compound was taken up with polar solvents such as MeOH, EtOH, DMF, DEF or NMP, which indicates that the solvent removal is completely reversible and the initial structure can be recovered (see Fig. 5e).
Fig. 6 Temperature-dependent weight loss of CFA-9 under flowing nitrogen (dashed line) and oxygen (solid line) gas.
Fig. 7 VTXRPD plots of CFA-9 kept in air and sampled in a temperature range of 30–550 °C. *Cu PDF no: 3-1015.
The argon adsorption isotherm for CFA-9 measured at 87.3 K (Fig. S4†) is typical of non-porous solids and reveals a BET surface area of only 11 m2 g−1. However, the sorption measurement with CO2 at 194.7 K reveals a much higher BET surface area of 189 m2 g−1 and shows a well-pronounced hysteresis in the relative pressure range 0.15–0.3 (Fig. 8), which is typical of breathing MOFs. The pore volume of np-CFA-9 determined from the adsorption branch of the CO2 isotherm at p/p0 = 0.1 is 0.051 cm3 g−1 while the volume of lp-CFA-9 determined from the adsorption branch of the CO2 isotherm at p/p0 = 0.99 is 0.115 cm3 g−1; both values correspond well to the calculated ones. The flexibility of the framework was additionally investigated by XRPD measurements under CO2 atmosphere (Fig. 9).
Fig. 8 CO2 adsorption/desorption isotherms at 194.7 K for CFA-9.
Fig. 9 XRPD plots of CFA-9 measured at −78.5 °C under vacuum (blue lines) and under increasing CO2 pressure (red lines) and decreasing CO2 pressure (grey lines).
The sample was cooled under vacuum to −78.5 °C and the pressure of CO2 was gradually increased up to 1000 mbar (red curves in Fig. 9) and then substantially decreased (grey curves). After changing from vacuum to a CO2 atmosphere, the intensity of the first five Bragg peaks decreased. With increasing CO2 pressure, new peaks occur (e.g. 9.67° 2θ at 100 mbar, 9.28° 2θ at 500 mbar, and 5.61° 2θ at 600 mbar). Next, decreasing the CO2 pressure leads to the same XRPD pattern as the one detected under vacuum (blue patterns).
The isosteric heat of CO adsorption determined from adsorption isotherms measured in the temperature range 203–223 K (Fig. S6†) lies at approx. 40 kJ mol−1 at low loading (<0.3 mmol g−1) and decreases to typical physisorption values of 17–20 kJ mol−1 at higher loading (Fig. 10). Such behaviour hints at weak binding of carbon monoxide to Cu(I) centers of CFA-9. Oxygen, in contrast, shows a constant physisorption heat of approx. 15 kJ mol−1 and thus does not bind to the Cu(I) centers.
Fig. 10 Dependencies of the isosteric heats of O2 (blue) and CO (green) adsorption on the loading for CFA-9.
Fig. 11 In situ DRIFT spectra of CFA-9 recorded in 20 °C steps upon cooling from 100 °C to −100 °C under a CO atmosphere (red lines) and subsequent heating from −100 °C to 100 °C under an Ar atmosphere (gray lines). The DRIFT spectrum of KBr at −60 °C under a CO atmosphere (black line).
In order to prove the reactivity of CFA-9 towards oxidizing reagents, the compound was oxidized by H2O2 or t-BuOOH and investigated by UV-vis spectroscopy. The solid-state UV-vis spectrum of CFA-9 displays one strong absorption peak at 318 nm in the UV region, which could be assigned to the intraligand electron transitions (Fig. 12). The UV-vis spectra of CFA-9 samples, oxidized by H2O2 or t-BuOOH, exhibit one additional broad peak with the maximum centered at ca. 600 nm, which encompasses the CuII d–d transitions.39 The XRPD patterns of the oxidized samples are similar to that of the CFA-9 sample (see Fig. S2†). Furthermore, the oxidized CFA-9 sample can be reduced back to a Cu(I)-MOF upon heating in DMF at 120 °C for 4 h. The XRPD pattern is also similar to that of the CFA-9 sample, indicating that the structure remains stable during this oxidation/reduction sequence.
Fig. 12 UV-vis spectra of CFA-9 at room temperature. Black line – CFA-9, red – CFA-9 oxidized by H2O2, blue – CFA-9 oxidized by t-BuOOH.
Fig. 13 XPS spectra of the Cu2p1/2 and Cu2p3/2 regions of CFA-9 (black), CFA-9 oxidized by H2O2 (red), and Cu(OAc)2 (blue).
Fig. 14 Peak shape analysis of the Cu2p3/2 peaks of a) CFA-9 (FWHM = 2.2 eV) and b) CFA-9 oxidized by H2O2 (FWHM = 4.4 eV).
Additionally, the reactivity of CFA-9 towards Br2 was investigated. 11.3 mg (0.01 mmol) of the sample was added to solutions of Br2 in CH2Cl2 (0.005, 0.01, 0.015, 0.02 and 0.05 mmol) and stirred for 15 minutes at r. t. The color of the samples changed from colorless to brown. Then, the samples were filtered off by suction, washed thoroughly with MeOH and dried. The samples were analyzed by EDX spectroscopy (Table 1) and X-ray diffraction (Fig. 15). Several attempts were undertaken to perform single-crystal X-ray diffraction measurements. Unfortunately, the quality of the Br2-treated crystals was not sufficient for the measurement. Instead, the samples were investigated by powder X-ray diffraction. The measurements show that the crystallinity of the framework is completely retained only when a 1 : 1 Br2/Cu ratio was applied. In this case, a product with an approx. Br/Cu ratio of 0.5 was obtained. Applying a higher initial Br2/Cu ratio allows the increase in the Br/Cu ratio in the product, but also leads to subsequent degradation of the framework.
Fig. 15 XRPD measurements of CFA-9 after reaction with Br2.
Pyrazolate-bridged complexes containing Cu(I) ions with d10 closed-shell electronic configuration are known to show luminescence.42 Upon irradiation with UV light, Cu(I) pyrazolates undergo a metal-to-ligand charge transfer resulting in a charge separated excited singlet state. This state can either decay to the ground state by emission of slightly red-shifted light, or undergo spin conversion into an excited triplet state, which shows slow decay (luminescence) to the ground state.43 The latter transition might be influenced by weak Cu⋯Cu interactions that typically occur in Cu(I) complexes and coordination polymers comprising bridging pyrazolate moieties. The usually broad luminescence band for Cu(I) pyrazolates is observed between ca. 460 and 660 nm (see Table 2). CFA-9 irradiated at 312 nm gave two broad emission bands with the maxima at 360 and 631 nm (Fig. 16). The luminescence behaviour of CFA-9 was almost the same as those previously reported in the literature and results from intramolecular Cu⋯Cu interactions (3.049(3)(intra) and 8.266(2)(inter) Cu⋯Cu distances in CFA-9).
Fig. 16 Solid-state photoluminescence spectra of CFA-9 and the H2-phbpz ligand at room temperature. Dashed-lines – excitation spectra, continuous-lines – emission spectra.
The work reported here focuses on the synthesis and characterization of a chiral metal–organic framework assembled from tetranuclear Cu(I) secondary building units and 3,3′,5,5′-tetraphenylbipyrazolate ligands. CFA-9 exhibits breathing effects upon exposure to different kinds of polar liquids (MeOH, EtOH, DMF, DEF, NMP), whereas non-polar solvents are not taken up at all. The framework flexibility results from the properties of the tetraphenylbipyrazolate ligand where two pyrazolate rings can rotate around the central C–C single bond. The interplanar angle changes from 60.7° (fully solvated state, lp-CFA-9) to 65.0–65.5° (fully desolvated form, np-CFA-9). The structural dynamics accompanying solvent removal and uptake in CFA-9 are connected with the changes of the crystal system from hexagonal to orthorhombic (np-CFA-9 phase) and back to hexagonal (lp-CFA-9 phase), respectively. The weak chemisorption of carbon monoxide on Cu(I) centers was confirmed by sorption and IR measurements, whereas no chemisorption of oxygen was observed. The reactions of CFA-9 with H2O2 or t-BuOOH indicate that the MOF is stable during repeated oxidation/reduction sequences.
Commercially available reagents of analytical grade were used as received without further purification.
Microwave irradiation method. A mixture of Cu(OAc)2·H2O (8 mg, 0.04 mmol) and H2-phbpz (30 mg, 0.06 mmol) was dissolved in MeOH (3 mL). 2,6-Dimethylpyridine (2,6-lutidine) (0.05 mL) was added and the solution was placed in a Pyrex sample tube (10 mL). The tube was closed with a cap and placed in a microwave synthesizer (CEM, Discover S). The resulting mixture was heated to 150 °C at 300 W for 25 min and then cooled to room temperature. The colourless microcrystalline material was filtered off by suction and washed thoroughly with MeOH. The synthesis can be similarly performed at larger quantities (upscale factor: 50). Yield: 8 mg, 33% (based on Cu(OAc)2·H2O). This material exhibited the same analytical results as the one obtained by the solvothermal method.
Physical methods. Fourier transform infrared (FTIR) spectra were recorded with ATR unit in the range 4000–400 cm−1 on a Bruker Equinox 55 FT-IR spectrometer. The following indicators are used to characterize absorption bands: very strong (vs), strong (s), medium (m), weak (w). Thermogravimetric analysis (TGA) was performed using a TGA Q500 analyzer in the temperature range of 25–800 °C in flowing nitrogen at a heating rate of 10 K min−1. Ar, CO, CO2 and O2 sorption isotherms were measured using a BELSORP-max instrument combined with a BELCryo system. The amounts of adsorbed gas are given in cm3 g−1 [STP], where STP = 101.3 kPa and 273.15 K. Prior to measurements, the sample was heated at 100 °C for 2 h under high vacuum in order to remove occluded solvent molecules. Ambient temperature X-ray powder diffraction (XRPD) patterns were measured using a Seifert XRD 3003 TT diffractometer equipped with a Meteor 1D detector operated at 40 kV, 40 mA, and CuKα (λ = 1.54247 Å) with a scan speed of 10 s per step and a step size of 0.02° in 2θ. The variable temperature XRPD data were collected in the 2θ range of 5–60° with 0.02° steps, using a Bruker D8 Advance diffractometer equipped with a Lynxeye linear position-sensitive detector, an MRI TCPU1 oven, in transmission geometry. The sample was loaded into a capillary (Hilgenberg) made from special glass no. 10, with 0.5 mm diameter and 0.01 mm wall thickness. The patterns were recorded in a temperature range from 30 to 250 °C, in the 5–60° 2θ range, with one step per 1 s and an angular step width of 0.02° in 2θ. The temperature program between measurements is as follows: a heating rate of 0.5 °C s−1 and then 10 min isothermal. The XRPD data under CO2 pressure were collected using an Empyrean (PANalytical) Diffractometer equipped with a Bragg–BrentanoHD mirror, a PICcel3D 2 × 2 detector and a Cryo & humidity Chamber CHC plus+ (Anton Paar). The sample was cooled under vacuum to −78.5 °C. Next, the pressure of CO2 was gradually increased up to 1000 mbar and then substantially decreased. The patterns were recorded in the 4–50° 2θ range, with one step per 185.4 s and an angular step width of 0.03° in 2θ. The diffuse reflectance Fourier-transform IR spectra (DRIFT) were collected between 3500–400 cm−1 using an Equinox 55 FT-IR spectrometer equipped with a Praying Mantis diffuse reflectance accessory and an environmental chamber (Harrick Scientific Products) and referenced to KBr. X-ray photoelectron spectra (XPS) were obtained by employing an Omicron spectrometer featuring a monochromatic Mg anode (XM 1000 Mk II, 1486.7 eV) and a hemispherical analyzer (EA 125). Each spectrum was collected from 925 to 960 eV with 120 to 160 sweeps. Energy-dispersive X-ray spectroscopy (EDX) was performed using a Philips XL 30 FEG scanning electron microscope equipped with an EDAX SiLi detector. Luminescence spectra were acquired using a spectrofluorimeter (FS920, Edinburgh Instruments) equipped with a TMS300 monochromator, an S900 single photon photomultiplier, and a Xe 900 450 W xenon arc lamp at r. t. The excitation and emission spectra were corrected for the wavelength-dependent lamp intensity and detector response, respectively.
Single-crystal X-ray diffraction. The crystal of lp-CFA-9 was collected from the mother liquor and mounted on a MiTeGen MicroMounts. The sample CFA-9 was dried in air and several crystals of np-CFA-9 were mounted on a MiTeGen MicroMounts and tested using a diffractometer. Unfortunately, most of the crystals scattered only up to 32° 2θ (1.3 Å resolution). Most of the dried crystals were cracked (see the SEM picture, Fig. 1). The best recorded data were obtained for a single crystal of np-CFA-9 with approx. dimensions of 121 × 49 × 66 μm3. X-ray data for the single crystal structure determinations of lp- and np-CFA-9 were collected using a Bruker D8 Venture diffractometer. Intensity measurements were performed using monochromated (doubly curved silicon crystal) MoKα radiation (0.71073 Å) from a sealed microfocus tube. The generator settings were 50 kV and 1 mA. The data collection temperature was −173 °C. APEX2 software was used for the preliminary determination of the unit cell.48 The determination of integrated intensities and unit cell refinement was performed using SAINT.49 The structures were solved and refined using the Bruker SHELXTL Software Package.50 Selected crystal data and details of structure refinements are provided in Table 3.
a R 1 = ∑‖F0| − |Fc‖/∑|F0|. b wR2 = ∑[w(F02 − Fc2)2]/∑[w(F02)2]1/2.
Financial support by the DFG (Priority Program SPP 1928 “COORNETs”) is gratefully acknowledged.
(a) J. Liu, L. Chen, H. Cui, J. Zhang, L. Zhang and C.-Y. Su, Chem. Soc. Rev., 2014, 43, 6011 RSC; (b) K. Leus, Y.-Y. Liu and P. Van Der Voort, Catal. Rev.: Sci. Eng., 2014, 56, 1 CrossRef CAS; (c) P. Silva, S. M. F. Vilela, J. P. C. Tomé and F. A. A. Paz, Chem. Soc. Rev., 2015, 44, 6774 RSC.
(a) J. Ren, H. W. Langmi, B. C. North and M. Mathe, Int. J. Energy Res., 2015, 39, 607 CrossRef CAS; (b) D. Banerjee, A. J. Cairns, J. Liu, R. K. Motkuri, S. K. Nune, C. A. Fernandez, R. Krishna, D. M. Strachan and P. K. Thallapally, Acc. Chem. Res., 2015, 48, 211 CrossRef CAS PubMed; (c) H. Furukawa, K. E. Cordova, M. O'Keeffe and O. M. Yaghi, Science, 2013, 341, 974 CrossRef CAS PubMed.
M. Giménez-Marqués, T. Hidalgo, C. Serre and P. Horcajada, Coord. Chem. Rev., 2016, 307, 342 CrossRef.
(a) L. Wang, Y. Han, X. Feng, J. Zhou, P. Qi and B. Wang, Coord. Chem. Rev., 2016, 307, 361 CrossRef CAS; (b) M. R. Ryder and J.-C. Tan, Mater. Sci. Technol., 2014, 30, 13a CrossRef.
A. Schneemann, V. Bon, I. Schwedler, I. Senkovska, S. Kaskel and R. A. Fischer, Chem. Soc. Rev., 2014, 43, 6062 RSC.
(a) C. R. Murdock, B. C. Hughes, Z. Lu and D. M. Jenkins, Coord. Chem. Rev., 2014, 258–259, 119 CrossRef CAS; (b) G. Férey, Chem. Soc. Rev., 2008, 37, 191 RSC.
SciFinder, American Chemical Society, 2016.
PubMed, National Center for Biotechnology Information, U.S. National Library of Medicine.
Web of Science, Thomson Reuters, 2015.
B. Mu, F. Li, Y. Huang and K. S. Walton, J. Mater. Chem., 2012, 22, 10172 RSC.
D. L. Reger, A. Leitner, P. J. Pellechia and M. D. Smith, Inorg. Chem., 2014, 53, 9932 CrossRef CAS PubMed.
(a) L. Ma, C. Abney and W. Lin, Chem. Soc. Rev., 2009, 38, 1248 RSC; (b) J. D. Evans and F.-X. Coudert, J. Am. Chem. Soc., 2016, 138, 6131 CrossRef CAS PubMed; (c) T. Sawano, P. Ji, A. R. McIsaac, Z. Lin, C. W. Abney and W. Lin, Chem. Sci., 2015, 6, 7163 RSC.
(a) Y. Cui, B. Li, H. He, W. Zhou, B. Chen and G. Qian, Acc. Chem. Res., 2016, 49(3), 483 CrossRef CAS PubMed; (b) M. Zhang, X. Chen, J. Zhang, J. Kong and L. Yuan, Chirality, 2016, 28(4), 340 CrossRef CAS PubMed.
(a) O. R. Evans and W. B. Lin, Acc. Chem. Res., 2002, 35, 511 CrossRef CAS PubMed; (b) C. Wang, T. Zhang and W. Lin, Chem. Rev., 2012, 112, 1084 CrossRef CAS PubMed.
(a) C.-L. Chang, X.-Y. Qi, J.-W. Zhang, Y.-M. Qiu, X.-J. Li, X. Wang, Y. Bai, J.-L. Sun and H.-W. Liu, Chem. Commun., 2015, 51, 3566 RSC; (b) Z. Chen, X. Liu, C. Zhang, Z. Zhang and F. Liang, Dalton Trans., 2011, 40, 1911 RSC.
L. Que and W. B. Tolman, Nature, 2008, 455, 333 CrossRef CAS PubMed.
L. Jian, C. Chen, F. Lan, S. Deng, W. Xiao and N. Zhang, Solid State Sci., 2011, 13, 1127 CrossRef CAS.
D. Jiang, T. Mallat, F. Krumeich and A. Baiker, J. Catal., 2008, 275, 390 CrossRef.
D. Jiang, T. Mallat, D. M. Meier, A. Urakawa and A. Baiker, J. Catal., 2010, 270, 26 CrossRef CAS.
N. T. S. Phan, P. H. L. Vu and T. T. Nguyen, J. Catal., 2013, 306, 38 CrossRef CAS.
(a) S. Marx, W. Kleist and A. Baiker, J. Catal., 2011, 281, 76 CrossRef CAS; (b) F. X. Llabres i Xamena, O. Casanova, R. Galiasso Tailleur, H. Garcia and A. Corma, J. Catal., 2008, 255, 220 CrossRef CAS; (c) S. Wang, L. Li, J. Zhang, X. Yuan and C.-Y. Su, J. Mater. Chem., 2011, 21, 7098 RSC.
C. Huang, J. Wu, C. Song, R. Ding, Y. Qiao, H. Hou, J. Chang and Y. Fan, Chem. Commun., 2015, 51, 10353 RSC.
(a) P.-Q. Liao, C.-T. He, D.-D. Zhou, J.-P. Zhang and X.-M. Chen, in The Chemistry of Metal–Organic Frameworks: Synthesis, Characterization and Applications, ed. S. Kaskel, Wiley, Weinheim, Germany, 2016, ch. 11, pp. 309–343 Search PubMed; (b) C. Pettinari, A. Tăbăcaru and S. Galli, Coord. Chem. Rev., 2016, 307, 1–31 CrossRef CAS; (c) J.-P. Zhang, Y.-B. Zhang, J.-B. Lin and X.-M. Chen, Chem. Rev., 2012, 112, 1001 CrossRef CAS PubMed.
M. Grzywa, C. Geßner, B. Bredenkötter, D. Denysenko, J. van Leusen, P. Kögerler, E. Klemm and D. Volkmer, Dalton Trans., 2014, 43, 16846 RSC.
D. Denysenko, M. Grzywa, J. Jelic, K. Reuter and D. Volkmer, Angew. Chem., Int. Ed., 2014, 53, 5832 CrossRef CAS PubMed.
M. Grzywa, C. Geßner, D. Denysenko, B. Bredenkötter, F. Gschwind, K. M. Fromm, W. Nitek, E. Klemm and D. Volkmer, Dalton Trans., 2013, 42, 6909 RSC.
(a) J.-X. Zhang, T.-T. Yan, J.-F. Kou, W.-H. Zhang and G. Yang, Z. Naturforsch., B: J. Chem. Sci., 2015, 70, 59 CAS; (b) A. Tăbăcaru, C. Pettinari, I. Timokhin, F. Marchetti, F. Carrasco-Marín, F. J. Maldonado-Hódar, S. Galli and N. Masciocchi, Cryst. Growth Des., 2013, 13, 3087 CrossRef.
J.-H. Wang, M. Li and D. Li, Chem. – Eur. J., 2014, 20, 12004 CrossRef CAS PubMed.
J. P. Freeman and J. F. Hansen, J. Chem. Soc., Chem. Commun., 1972, 961 RSC.
W. M. Haynes, Handbook of Chemistry and Physics, CRC Press, Cleveland, 2013 Search PubMed.
V. A. Blatov, IUCr CompComm Newsletter, 2006, vol. 7, pp. 4–38 Search PubMed.
Y. Tanaka, T. Kojima, Y. Takata, A. Chainani, S. W. Lovesey, K. S. Knight, T. Takeuchi, M. Oura, Y. Senba, H. Ohashi and S. Shin, Phys. Rev. B: Condens. Matter Mater. Phys., 2010, 81, 144104 CrossRef.
J. C. Wojdeł, M. A. Zwijnenburg and S. T. Bromley, Chem. Mater., 2006, 18, 1464 CrossRef.
H. V. R. Dias and H.-L. Lu, Inorg. Chem., 1995, 34, 5380 CrossRef CAS.
H. V. R. Dias and H.-J. Kim, Organometallics, 1996, 15, 5374 CrossRef CAS.
K. Fujisawa, T. Ono, Y. Ishikawa, N. Amir, Y. Miyashita, K. Okamoto and N. Lehnert, Inorg. Chem., 2006, 45, 1698 CrossRef CAS PubMed.
L. Y. Fager and J. O. Alben, Biochemistry, 1972, 11, 4786 CrossRef CAS PubMed.
(a) F. G. Mutti, M. Gullotti, L. Casella, L. Santagostini, R. Pagliarin, K. K. Andersson, M. F. Iozzi and G. Zoppellaro, Dalton Trans., 2011, 40, 5436 RSC; (b) C. Di Nicola, Y. Y. Karabach, A. M. Kirillov, M. Monari, L. Pandolfo, C. Pettinari and A. J. L. Pombeiro, Inorg. Chem., 2007, 46, 221 CrossRef CAS PubMed.
(a) M. C. Biesinger, L. W. M. Lau, A. R. Gerson and R. St. C. Smart, Appl. Surf. Sci., 2010, 257, 887 CrossRef CAS; (b) C. Huang, J. Wu, C. Song, R. Ding, Y. Quiao, H. Hou, J. Chang and Y. Fan, Chem. Comm., 2015, 51, 10353 RSC; (c) A. S. Duke, E. A. Dolgopolova, R. P. Galhenage, S. C. Ammal, A. Heyden, M. D. Smith, D. A. Chen and N. B. Shustova, J. Phys. Chem. C, 2015, 119, 27457 CrossRef CAS.
E. S. Shpiro, W. Grünert, R. W. Joyner and G. N. Baeva, Catal. Lett., 1994, 24, 159 CrossRef CAS.
(a) Y. Cui, Y. Yue, G. Qian and B. Chen, Chem. Rev., 2012, 112, 1126 CrossRef CAS PubMed; (b) K. Fujisawa, Y. Ishikawa, Y. Miyashita and K. Okamoto, Inorg. Chim. Acta, 2010, 363, 2977 CrossRef CAS; (c) H. V. R. Dias, H. V. K. Diyabalanage, M. G. Eldabaja, O. Elbjeirami, M. A. Rawashdeh-Omary and M. A. Omary, J. Am. Chem. Soc., 2005, 127, 7489 CrossRef CAS PubMed; (d) Q. Xiao, J. Zheng, M. Li, S.-Z. Zhan, J.-H. Wang and D. Li, Inorg. Chem., 2014, 53, 11604 CrossRef CAS PubMed.
(a) N. Armaroli, G. Accorsi, F. Cardinali and A. Listorti, in Curr Chem, ed. V. Balzani and S. Campagna, Springer-Verlag, Berlin Heidelberg, Germany, 2007, vol. 280, pp. 69–115 Search PubMed; (b) P. C. Ford, W. Cariati and J. Bourassa, Chem. Rev., 1999, 99, 3625 CrossRef CAS PubMed.
J. He, Y.-G. Yin, T. Wu, D. Li and X.-C. Huang, Chem. Comm., 2006, 2845 RSC.
C. V. Hettiarachchi, M. A. Rawashdeh-Omary, D. Korir, J. Kohistani, M. Yousufuddin and H. V. R. Dias, Inorg. Chem., 2013, 52, 13576 CrossRef CAS PubMed.
L. Hou, W.-J. Shi, Y.-Y. Wang, H.-H. Wang, L. Cui, P.-X. Chen and Q.-Z. Shi, Inorg. Chem., 2011, 50, 261 CrossRef CAS PubMed.
J.-X. Zhang, J. He, Y.-G. Yin, M.-H. Hu, D. Li and X.-C. Huang, Inorg. Chem., 2008, 47, 3471 CrossRef CAS PubMed.
APEX2 Version 2011.6, Bruker AXS Inc Search PubMed.
SAINT Version 8.32B, Bruker AXS Inc., 2013 Search PubMed.
XL Version 2013/3, G. M. Sheldrick, Acta Crystallogr., Sect. A: Found. Crystallogr., 2008, 64, 112 CrossRef CAS PubMed.

References: V. 

V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.